Kanamycin

Kanamycin is an aminoglycoside antibiotic used to treat a variety of bacterial infections. It works by inhibiting bacterial protein synthesis, leading to cell death. It is often used to treat severe infections such as pneumonia, meningitis, and sepsis. It can also be used to prevent bacterial endocarditis in certain high-risk patients. Kanamycin is available as an oral and intravenous solution. Common side effects include nausea, vomiting, and diarrhea.

Kanamycin is a prescription antibiotic belonging to the aminoglycoside class. While effective against a broad spectrum of bacteria, its use is limited due to potential side effects and the availability of safer alternatives. Here's a breakdown of its key points:

Function:

  • Blocks Protein Synthesis: Kanamycin works by interfering with the bacteria's ability to produce essential proteins, ultimately hindering their growth and reproduction.

Applications:

  • Severe Bacterial Infections: Previously used to treat various serious infections caused by susceptible bacteria, including:
    • Sepsis: A life-threatening condition caused by the body's response to an infection.
    • Urinary tract infections (UTIs)
    • Pneumonia
    • Meningitis
    • Gastrointestinal infections

Current Status:

  • Limited Use: Due to concerns about:
    • Side Effects: Kanamycin can cause serious side effects, including:
      • Ototoxicity (hearing loss): A major concern, especially with prolonged use.
      • Nephrotoxicity (kidney damage): Can be particularly risky for individuals with pre-existing kidney problems.
    • Resistance: Increased bacterial resistance to Kanamycin has reduced its effectiveness in certain cases.
  • Alternative Antibiotics: Safer and more effective antibiotics are often preferred for treating many infections.

Important Information:

  • Not a first-line treatment: Due to the potential side effects, Kanamycin is typically reserved for severe infections where safer alternatives are ineffective.
  • Requires doctor's prescription and monitoring: Only a healthcare professional can assess the risks and benefits and prescribe Kanamycin when necessary, along with close monitoring during treatment.
Anatomical Therapeutic Chemical Classification
A - Alimentary tract and metabolism
A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
A07A - Intestinal anti-infectives
A07AA Antibiotics
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J01 Antibacterials for systemic use
J01G - Aminoglycoside antibacterials
J01GB Other aminoglycosides
Anatomical Therapeutic Chemical Classification
S - Sensory organs
S01 Ophthalmologicals
S01A - Anti-infectives
S01AA Antibiotics
External Links